We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
PCVX icon
26
Vaxcyte
PCVX
$9.8B
$9.8B $62.03 0.93%
CAI icon
27
Caris Life Sciences
CAI
$9.7B
$9.7B $34.33 5.01%
PTGX icon
28
Protagonist Therapeutics
PTGX
$9.37B
$9.37B $144.85 0.35%
TGTX icon
29
TG Therapeutics
TGTX
$9.36B
$9.36B $61.18 5.34%
SYRE icon
30
Spyre Therapeutics
SYRE
$9.02B
$9.02B $96.56 2.43%
IBRX icon
31
ImmunityBio
IBRX
$8.79B
$8.79B $8.29 5.15%
CORT icon
32
Corcept Therapeutics
CORT
$8.77B
$8.77B $81.12 5.62%
CYTK icon
33
Cytokinetics
CYTK
$8.76B
$8.76B $62.99 0.51%
ARWR icon
34
Arrowhead Research
ARWR
$8.46B
$8.46B $59.90 0.98%
PRAX icon
35
Praxis Precision Medicines
PRAX
$7.98B
$7.98B $285.93 0.93%
ABVX icon
36
Abivax
ABVX
$7.58B
$7.58B $86.59 2.77%
AXSM icon
37
Axsome Therapeutics
AXSM
$7.57B
$7.57B $144.43 0.68%
IONS icon
38
Ionis Pharmaceuticals
IONS
$7.23B
$7.23B $43.52 1.96%
LGND icon
39
Ligand Pharmaceuticals
LGND
$6.43B
$6.43B $322.75 1.71%
ORKA icon
40
Oruka Therapeutics
ORKA
$6.41B
$6.41B $96.87 0.23%
RYTM icon
41
Rhythm Pharmaceuticals
RYTM
$6.37B
$6.37B $92.57 0.54%
KOD icon
42
Kodiak Sciences
KOD
$6.23B
$6.23B $99.18 1.22%
BLTE icon
43
Belite Bio
BLTE
$6.23B
$6.23B $154.74 2.97%
IMVT icon
44
Immunovant
IMVT
$6.03B
$6.03B $29.17 1.59%
MANE icon
45
Veradermics Inc
MANE
$5.84B
$5.84B $139.69 2.89%
CGON icon
46
CG Oncology
CGON
$5.73B
$5.73B $64.68 1.91%
MIRM icon
47
Mirum Pharmaceuticals
MIRM
$5.52B
$5.52B $85 1.61%
COGT icon
48
Cogent Biosciences
COGT
$5.38B
$5.38B $31.02 2.94%
SRRK icon
49
Scholar Rock
SRRK
$5.35B
$5.35B $43.90 0.63%
ERAS icon
50
Erasca
ERAS
$5.02B
$5.02B $14.35 4.21%
1
2
3 4 5

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.31T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $142B, Regeneron Pharmaceuticals (REGN) at $96B and Moderna (MRNA) at $88.5B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.